Skip to main content
. 2020 Aug 12;12(8):2252. doi: 10.3390/cancers12082252
2-DG 2-Deoxy-D-glucose
3-BrPy 3-bromopyruvate
3-PO 3-(3-pyridinyl)-1-(4-pyridinyl)-2-propen-1-one
6-AN 6-aminonicotinamide
AKT Protein kinase B
AMPK 5’ adenosine monophosphate-activated protein kinase
ASCT2 Alanine-, serine-, cysteine transporter 2
ATO Arsenic trioxide
ATP Adenosine triphosphate
BC Breast cancer
BSO Buthionine sulfoximine
CHC α-cyano-4-hydroxycinnamate
DCA Dichloroacetate
ECM Extracellular matrix
EGFR Epidermal growth factor receptor
EN Enolase
ER Estrogen receptor
GAPDH Glyceraldehyde-3-phosphate dehydrogenase
GLUT Glucose transporter
HIF-1α Hypoxia inducible factor alpha
HK Hexokinase
HSF1 Heat shock factor 1
IC50 Half maximal inhibitory concentration
IGFR Insulin-like growth factor receptor
LDHA Lactate Dehydrogenase A
MCP Mitochondrial pyruvate carrier
MCT1 Monocarboxylate transporter 1
MDR Multidrug resistance
MET Mesenchymal-epithelial transition factor
OCT4 Octamer binding transcription factor/protein 4
P-gp Permeability glycoprotein
PAMAM-PTX Paclitaxel-conjugated polyamidoamine
PDTC Pyrrolidine dithiocarbamate
PFK Phosphofructokinase
PFKFB3 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 3
PI3K Phosphatidylinositol 3-kinase
PK Pyruvate kinase
PPP Pentose phosphate pathway
Ras Rat sarcoma viral proto-oncogene
ROS Reactive oxygen species
RTK Receptor tyrosine kinase
SOX2 Sex determining region Y Box 2
TCA Tricarboxylic acid cycle
TNBC Triple negative breast cancer
UA Ursolic acid
VEGFα Vascular endothelial growth factor alpha
WT Wildtype